Prelude Capital Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-62,847
| Closed | -$1.17M | – | 1366 |
|
|
2023
Q3 | $1.17M | Buy |
+62,847
| New | +$1.17M | 0.08% | 229 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 1816 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 1730 |
|
|
2021
Q1 | – | Sell |
-13,830
| Closed | -$342K | – | 1468 |
|
|
2020
Q4 | $342K | Buy |
+13,830
| New | +$342K | 0.01% | 472 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 1976 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 1792 |
|
|
2019
Q4 | – | Sell |
-151
| Closed | -$10K | – | 1855 |
|
|
2019
Q3 | $10K | Sell |
151
-3
| -2% | -$199 | ﹤0.01% | 1020 |
|
|
2019
Q2 | $12K | Sell |
154
-20
| -11% | -$1.56K | ﹤0.01% | 989 |
|
|
2019
Q1 | $19K | Buy |
174
+101
| +138% | +$11K | ﹤0.01% | 959 |
|
|
2018
Q4 | $7K | Hold |
73
| – | – | ﹤0.01% | 1136 |
|
|
2018
Q3 | $9K | Sell |
73
-13,070
| -99% | -$1.61M | ﹤0.01% | 1135 |
|
|
2018
Q2 | $1.1M | Buy |
+13,143
| New | +$1.1M | 0.07% | 222 |
|
|
2017
Q4 | – | Sell |
-1,754
| Closed | -$102K | – | 1663 |
|
|
2017
Q3 | $102K | Sell |
1,754
-15,813
| -90% | -$920K | 0.01% | 794 |
|
|
2017
Q2 | $2.13M | Buy |
17,567
+16,107
| +1,103% | +$1.95M | 0.2% | 102 |
|
|
2017
Q1 | $165K | Buy |
+1,460
| New | +$165K | 0.02% | 585 |
|
|
2015
Q1 | – | Hold |
0
| – | – | – | 2143 |
|
|
2014
Q4 | – | Hold |
0
| – | – | – | 2088 |
|